Roche Diagnostics inks $420m deal in Suzhou
China DailyRoche Diagnostics Products Co Ltd signs an agreement with the Suzhou Industrial Park Administrative Committee to invest 3 billion yuan in the expansion of Roche Diagnostics Asia Manufacturing and R&D Site in Suzhou, Jiangsu province, on Aug 21, 2024. Roche Diagnostics Products Co Ltd has signed an agreement with the Suzhou Industrial Park Administrative Committee to invest 3 billion yuan in expanding its existing site in Suzhou, Jiangsu province. "Upon completion, the Roche Diagnostics Asia Manufacturing and R&D Site plans to manufacture more than 400 products, including both reagents and instruments, by 2030, compared to 120 products today," said Marco Cairoli, general manager of Roche Diagnostics Asia Manufacturing and R&D Site. Richard Yiu, general manager of Roche Diagnostics China, said the investment reaffirms Roche Diagnostics' commitment to providing innovative diagnostics solutions for Chinese patients that enable earlier and better disease detection and monitoring.
History of this topic
Roche Diagnostics opens new China head office, celebrates Group Open Innovation certification
China Daily
Roche Pharmaceuticals to showcase innovative treatments at CIIE
China DailyDiscover Related
)
)
)
)
